"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
2,13,"Withdrawals due to adverse events","CKD stage 3Ga (transplant)","SUBGROUP_AND_OVERALL","Guida 2014",2014,0,0,0,0,0,18,0,0,0,12,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
2,13,"Withdrawals due to adverse events","CKD stage 3Ga (transplant)","SUBGROUP_AND_OVERALL","Guida 2017",2017,0,0,0,0,0,22,0,0,0,12,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
2,13,"Withdrawals due to adverse events","CKD stage G5D","SUBGROUP_AND_OVERALL","Lopes 2018",2018,0,0,0,0,10,49,0,0,13,50,0,0,100,0.784929,0.380478,1.619317,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
2,13,"Withdrawals due to adverse events","CKD stage G5D","SUBGROUP_AND_OVERALL","Mirzaeian 2020",2020,0,0,0,0,0,24,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
3,13,"GI function: microbiota composition (Proteobacteria) at 4 weeks","CKD stage G5D with diabetes","SUBGROUP_AND_OVERALL","Biruete 2017",2017,0,0,2.15,2.68,0,12,2.04,1.44,0,12,0,0,100,0.11,-1.61135,1.83135,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
8,13,"Withdrawals due to adverse events","CKD stage G5D","SUBGROUP_AND_OVERALL","Borges 2018",2018,0,0,0,0,5,23,0,0,1,23,0,0,51.169531,5,0.632332,39.536215,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
8,13,"Withdrawals due to adverse events","CKD stage G5D","SUBGROUP_AND_OVERALL","Eidi 2018",2018,0,0,0,0,2,30,0,0,0,29,0,0,24.397577,4.83871,0.242213,96.663153,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
8,13,"Withdrawals due to adverse events","CKD stage G5D with diabetes and hypertension","SUBGROUP_AND_OVERALL","Lim 2021",2021,0,0,0,0,2,28,0,0,0,28,0,0,24.432892,5,0.25083,99.669246,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
8,13,"Withdrawals due to adverse events","CKD stage 1 and type 2 diabetes","SUBGROUP_AND_OVERALL","Abbasi 2017",2017,0,0,0,0,0,22,0,0,0,22,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013631.pub2/full","10.1002/14651858.CD013631.pub2","13::overall","CD013631_pub2_data","significance_only",TRUE,FALSE,TRUE,0.157812183620405,0.0636700760886381,-0.57527926623421,0.890903633475019,0.00592953070587764,0.121410621471399,TRUE,TRUE
